NCT00095069View on ClinicalTrials.gov

Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Insomnia
Interventions
DRUG

MK0928, gaboxadol / Duration of Treatment - 1 year

DRUG

Comparator: placebo / Duration of Treatment -1 year

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT00095069 - Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED) | Biotech Hunter | Biotech Hunter